SWATH proteomic analysis from the standard care versus celecoxib outcome trial identifies renal biomarkers are associated with early cardiovascular events amongst NSAID users

28 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Clinical and basic science insights in vascular disease Biomarkers ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by